Oslo Balloon Angioplasty Versus Conservative Treatment
Sponsor: Pfizer
A NA clinical study on Peripheral Vascular Disease, this trial is completed. The trial is conducted by Pfizer and has accumulated 5 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Nov 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
- Ullevaal University Hospital
- University Hospital, Aker
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.